A $60B+ pharma company that's undervalued with a 100%+ upside

I'm very selective about pharma companies, but this one is a "Buy"

I sold out of pharma some years ago during the peak, including most of my positions at the time. What I have still are so-called medtech companies, which focus on technology and machines instead - these are undervalued at this time.

However, you can find some undervalued gems that don’t have an unappealing risk profile, and this company is one such business.

With a $60B+ market cap, a yield of over 4%, and an upside of over 100% in a few years, I have a 1% stake in this company based on my portfolio size. '